Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil.
about
Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Poor response to azithromycin ...... III clinical trial in Brazil.
@en
Poor response to azithromycin ...... III clinical trial in Brazil.
@nl
type
label
Poor response to azithromycin ...... III clinical trial in Brazil.
@en
Poor response to azithromycin ...... III clinical trial in Brazil.
@nl
prefLabel
Poor response to azithromycin ...... III clinical trial in Brazil.
@en
Poor response to azithromycin ...... III clinical trial in Brazil.
@nl
P2093
P2860
P50
P1476
Poor response to azithromycin ...... e III clinical trial in Brazil
@en
P2093
Ana Rabello
Sílvio Fernando Guimarães Carvalho
Thaís Alves Amaral
P2860
P304
P356
10.1590/0037-8682-0266-2014
P577
2014-11-01T00:00:00Z